These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 7528953)
1. Functional expression of human CD59 in transgenic mice. Somerville CA; Kyriazis AG; McKenzie A; Allison J; Pearse MJ; D'Apice AJ Transplantation; 1994 Dec; 58(12):1430-5. PubMed ID: 7528953 [No Abstract] [Full Text] [Related]
2. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection. Cary N; Moody J; Yannoutsos N; Wallwork J; White D Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815 [No Abstract] [Full Text] [Related]
3. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279 [TBL] [Abstract][Full Text] [Related]
4. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation. Capey S; van den Berg CW Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772 [TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of alpha-1,2-fucosyltransferase, DAF, and CD59 in suppression of xenogenic immunological responses. Li SZ; Qu YC; Liu BQ; Wang GY; Zhang Y; Ma ZF; Ma TX; Qiu M; Han RF Xenotransplantation; 2009; 16(1):27-33. PubMed ID: 19243558 [TBL] [Abstract][Full Text] [Related]
6. Expression and function of human CD59 and human CD55 in transgenic mice. Somerville C; van Denderen B; Adam B; Aminian A; Allison J; Pearse M; d'Apice A Transplant Proc; 1995 Dec; 27(6):3565-6. PubMed ID: 8540103 [No Abstract] [Full Text] [Related]
7. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells. Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040 [TBL] [Abstract][Full Text] [Related]
8. Cell- and tissue-specific expression of a human CD59 minigene in transgenic mice. Diamond LE; Oldham ER; Platt JL; Waldmann H; Tone M; Walsh LA; Logan JS Transplant Proc; 1994 Jun; 26(3):1239. PubMed ID: 7518115 [No Abstract] [Full Text] [Related]
9. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion. McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395 [TBL] [Abstract][Full Text] [Related]
10. Functional feature of C5b-8-step lysis of swine endothelial cell- transfected CD59. Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Matsuda H; Terado A; Hatanaka M; Matsumoto M; Seya T Transplant Proc; 1996 Apr; 28(2):597-8. PubMed ID: 8623293 [No Abstract] [Full Text] [Related]
11. CD46 (MCP) confers protection from lysis by xenogeneic antibodies. Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF Transplant Proc; 1993 Feb; 25(1 Pt 1):396-7. PubMed ID: 8438351 [No Abstract] [Full Text] [Related]
12. Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis. Charreau B; Cassard A; Tesson L; Le Mauff B; Blanchard D; Lublin D; Soulillou JP; Anegon I Transplant Proc; 1995 Feb; 27(1):336-7. PubMed ID: 7533404 [No Abstract] [Full Text] [Related]
13. Enhancement of the complement regulatory function of CD59 by site-directed mutagenesis at the N-glycosylation site. Akami T; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Nakai I; Mitsuo M; Sawada R; Naruto M; Oka T Transplant Proc; 1994 Jun; 26(3):1256-8. PubMed ID: 7518124 [No Abstract] [Full Text] [Related]
14. In vitro and in vivo studies to prevent hyperacute rejection. Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217 [No Abstract] [Full Text] [Related]
15. Development and analysis of transgenic pigs expressing the human complement regulatory protein CD59 and DAF. Byrne G; McCurry K; Martin M; Platt J; Logan J Transplant Proc; 1996 Apr; 28(2):759. PubMed ID: 8623385 [No Abstract] [Full Text] [Related]
16. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation. Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114 [No Abstract] [Full Text] [Related]
17. Cytoprotective effect of CD59 antigen on xenotransplantation immunity. Akami T; Sawada R; Minato N; Naruto M; Yamada A; Imanishi J; Mitsuo M; Nakai I; Okamoto M; Nakajima H Transplant Proc; 1992 Apr; 24(2):485-7. PubMed ID: 1373542 [No Abstract] [Full Text] [Related]